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Activation of TRPV1 channels in sensory nerves by capsaicin promotes neuropeptide release, leading to
the perception of pain and inflammation. In this issue, Yang et al. (2010) demonstrate that vascular TRPV1
mediates a beneficial effect of capsaicin in the cardiovascular system, promoting nitric oxide release and
lowering blood pressure.Transient receptor potential (TRP) chan-
nels serve as receptors for a diverse
series of biological ligands, including
temperature, mechanical forces, and
noxious chemicals, and are implicated in
several diseases, including cardiovas-
cular and neurological diseases, asthma,
cancer, and renal disease (Nilius and
Owsianik, 2010). One member of the
TRP vaniloid cation channel family,
TRPV1, is strongly activated by a pungent
ingredient of ‘‘hot peppers’’ called capsa-
icin (8-methyl-N-vanillyl-6-nonenamide).
Capsaicin binding to TRPV1 triggers an
increase in intracellular calcium, which
causes the release of several neuropep-
tides, such as substance P and calcitonin
gene-related peptide (cGRP). When this
occurs in sensory nerves, it promotes
the sensation of pain, inflammation, and
of the local heat from the ingested chili
peppers. When administered locally in
over-the-counter products applied to the
skin, capsaicin promotes analgesia via
desensitization of sensory nerves. Where-
as the role of TRPV1 expressed in sensory
nerves is well described, the role of
TRPV1 in other cell types, such as blood
vessels, is less appreciated.
In this issue of Cell Metabolism, Yang
et al (2010) provide compelling evidence
supporting the idea that capsaicin can
improve blood vessel function and lower
blood pressure via activation of TRPV1
localized in endothelial cells that line all
blood vessels of the body. Endothelial
cells are specialized cells localized at the
interface between blood and tissue and
are critical for several aspects of cardio-
vascular homeostasis, including throm-
bosis and hemostasis, blood flow control,
and delivery of oxygen and nutrients
throughout the body (Pober and Sessa,2007). Accordingly, endothelial cell dys-
function is a common manifestation of
multiple cardiovascular diseases such as
atherosclerosis, stroke, cardiac dys-
function, and hypertension. One aspect
of endothelial dysfunction easily mea-
sured in patients and in animal models
of cardiovascular disease is the inability
of blood vessels to produce or respond
to nitric oxide (NO). In blood vessels, NO
is produced by the enzyme endothelial ni-
tric oxide synthase (eNOS), a peripheral
membrane protein found in all endothelial
cells, which is activated by mechanical
forces (flow and pressure) in the cardio-
vascular system to liberate NO. NO, in
turn, can promote relaxation of blood
vessels via activation of soluble guanylyl
cyclase, thus maintaining normal blood
flow and pressure. eNOS is regulated by
fluctuations in calcium, dynamic protein-
protein interactions, and by its phosphor-
ylation state. A current model for eNOS
activation is that increases in intracellular
calcium results in the binding of calmod-
ulin to eNOS, displacing the inhibitory
interaction of eNOS with the protein
caveolin-1 and promoting the binding of
hsp90 and phosphorylation of eNOS by
several potential kinases, including Akt,
protein kinase A, and AMPK (Sessa,
2004). Phosphorylation of eNOS on serine
1177 (S1177 in human and S1176 in
mouse) results in a marked increase in
NO release and is considered a surrogate
readout for eNOS activation in most
systems studied.
Previous work has shown that TRPV1 is
present in endothelial cells (Inoue et al.,
2006) and that capsaicin increases
eNOS protein levels and NO production
(Lo et al., 2003). Mice lacking TRPV1 are
not hypertensive (Pacher et al., 2004;Cell Metabolism 1Wang and Wang, 2009) per se, as are
mice lacking eNOS (Shesely et al., 1996);
however, when mice lacking TRPV1 are
uninephrectomized and fed a deoxy-
corticosterone/high-salt diet (a standard
method for inducing hypertension), they
exhibit enhanced renovascular inflamma-
tion (Wang and Wang, 2009). However,
the mechanisms and physiological rele-
vance of sustained activation of TRPV1
by capsaicin were not clear. Yang et al.
(2010) demonstrate that capsaicin in-
creases calcium and eNOS S1177
phosphorylation in a TRPV1-dependent
mechanism because capsaicin-induced
activation is reduced in endothelial cells
isolated from TRPV1-deficient mice. Re-
markably, feeding mice capsaicin chroni-
cally (for 6 months) increases TRPV1
expression and eNOS phosphorylation in
mesenteric arteries, an effect eliminated
in mice lacking TRPV1. To identify the
potential kinases activated by TRPV1-
mediated increases in calcium, inhibitors
were used. For example, removal or
chelation of calcium abrogates capsa-
icin-stimulated PKA activation and eNOS
phosphorylation, an effect mimicked by
blockade of protein kinase A, suggesting
a TRPV1-PKA-eNOS pathway. However,
TRPV1-mediated calcium entry is re-
quired for both PKA and eNOS phos-
phorylation, and the effects of PKA
inhibitors on intracellular calcium are
potentially complex because PKA can
directly phosphorylate TRPV1 to reduce
TRPV1 desensitization and thereby influ-
ence calcium dynamics (Bhave et al.,
2002). Thus, it is difficult to unequivocally
assign PKA as the eNOS kinase in these
experiments or to clearly demonstrate
how changes in calcium promote eNOS
phosphorylation.2, August 4, 2010 ª2010 Elsevier Inc. 109
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PreviewsAs suggested in this study, acute acti-
vation of PKA and eNOS could explain,
in part, the ability of TRPV1 agonist to
relax blood vessels. But what about over-
all changes in systemic blood pressure?
To test the hemodynamic effects of sus-
tained capsaicin feeding, spontaneously
hypertensive rats (a model of primary
hypertension) and control rats were fed a
capsaicin-rich diet for 7 months, followed
by evaluation of endothelium-dependent
function in isolated blood vessels and
telemetric evaluation of blood pressure.
Remarkably, capsaicin feeding improved
vascular function and reduced blood
pressure in SHR rats. This was associated
with elevated levels of NO in blood and
PKA and eNOS phosphorylation in iso-
lated blood vessels. Thus, capsaicin
improves impaired endothelial function
and lowers blood pressure.
Although these data are provocative,
there are several outstanding questions
that need to be addressed; namely, what
are the mechanisms of capsaicin upregu-
lation of TRPV1 protein levels, and are110 Cell Metabolism 12, August 4, 2010 ª201PKA and/or eNOS required for the blood
pressure-lowering actions of capsaicin?
Also, TRPV1 in sensory nerves and neuro-
peptides liberated by activation of TRPV1
can interact with other neurohormonal
systems, including the sympathetic ner-
vous system, the renin-angiotensin sys-
tem, and the endothelin system, all of
which regulate aspects of cardiovascular
and renal function. Thus, deleting TRPV1
in sensory nerves versus vasculature in
mice would be highly informative to
discriminate the role of sensory nerve
input versus direct vascular effects of
capsaicin. Nevertheless, the recent study
by Yang et al. provides an interesting
perspective on the potential benefits of
consuming a capsaicin-enriched diet as
a possible approach to reduce blood
pressure.if you can take the heat!REFERENCES
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